Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Zeneca describes ET antagonists

Feb. 14, 1997

Retinoid series for cancer

Feb. 14, 1997

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

X-ray contrast agents from Schering AG

Feb. 14, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

ZymoGenetics/Novo Nordisk isolate anticlotting agent

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Neutrophil-stimulating peptides derived from TNF described by Peptech

Feb. 13, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Sugen reports modulators of tyrosine signal transduction

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...